Everest Organics Ltd Share Price

Everest Organics
Small Cap | Pharmaceuticals
₹ 382.1 -17.9 (-4.47%)
Last updated: 04-Nov-2025 , 16:01:40

Everest Organics Ltd Live Price Chart

Low: ₹382.05 High: 412.95
Open Your Trading & Demat Account
+91

Everest Organics Ltd Technicals

Current Price
₹ 382.1 -17.9 (-4.47%)
EMASMA
20 Day ₹ 397.731
50 Day ₹ 392.693
100 Day ₹ 377.194
200 Day ₹ 339.041
20 Day ₹ 397.090
50 Day ₹ 401.342
100 Day ₹ 373.732
200 Day ₹ 342.494

Everest Organics Ltd Performance

Previous Close ₹ 400
High ₹ 412.95
Volume 4022
52W Range ₹ 112.5 - ₹ 477
Open ₹ 404
Low ₹ 382.05
Market Cap 375.41 Cr

Everest Organics Ltd Fundamentals

ROCE 1.653
P/E Ratio 60.500
P/B Ratio 5.440
Industry P/E 5.440
Debt to Equity 40.807
ROE -1.845
EPS 6.390
Dividend Yield 0.000
Book Value 71.002
Face Value 10.000

Everest Organics Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 160.1659 198.1274 189.992 202.2579 182.6286
Total Expenses 163.4084 197.517 189.9021 200.5186 165.355
Profit After Tax -1.2903 0.1392 -0.1822 1.1437 13.715

Everest Organics Ltd Shareholding Pattern

Promoter Holdings 59.642 %
FIIs 0.000 %
DIIs 0.023 %
MutualFund 0.000 %
Retail 25.985 %
Others - 14.350 %

About Everest Organics Ltd

History of Everest Organics Ltd

Everest Organics Limited was incorporated at Hyderabad in February, 1993. It was promoted by S K Srihari Raju and S K. Chittiramabhadra Raju. The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries. The Company commenced its commercial operations in the year 1993. It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations. It came out with a public issue in Jan.'95 to part-finance the project. Commercial production of ciprofloxacin and omerprazole commenced in Feb.'96. The company preferred to manufacture para hydroxy phynyl glycin (PHPG), but due to market conditions, it decided to drop manufacturing of PHPG and has decided to enhance the capacity of ciprofloxacin from 30 tpa to 120 tpa and also to manufacture enr ...

Similar Stocks

Company 52 Week Market Price P/E Ratio
Gujarat Themis Biosyn Ltd ₹ 208 - ₹ 479 460 112.84
Jubilant Pharmova Ltd ₹ 802 - ₹ 1309.9 1178 1027.17
Anuh Pharma Ltd ₹ 74.25 - ₹ 122.85 87.41 19.06
Aarti Drugs Ltd ₹ 312 - ₹ 564.05 505 25.86
Aarey Drugs & Pharmaceuticals Ltd ₹ 31.35 - ₹ 98.17 98.16 66.78

FAQs on Everest Organics Ltd

1. Can I buy Everest Organics Ltd from PL Capital? ›

Yes, you can invest in Everest Organics Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Everest Organics Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Everest Organics Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Everest Organics Ltd pay dividends? ›

Everest Organics Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Everest Organics Ltd ? ›

As of 04-11-2025 the share price for Everest Organics Ltd. is 386.6 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Everest Organics Ltd ? ›

The 52-week high and low of Everest Organics Ltd share price is ₹ 112.5 - ₹ 477 as of 04-11-2025 .
PL Ringside View

Our fireside chat series where industry experts and top management share valuable insights for our clients

Youtube

Mark Mobius on India’s Growth, Global Markets, and Investment Opportunities

Youtube

₹100 cr net profit in 7-12 months | Anjali Nashier, Revolt Motors

Youtube

India's Path to Energy Security | Dr. Praveer Sinha, MD & CEO, Tata Power

  • PL Capital Logo

  • Regd. Office : 3rd Floor, Sadhana House,
    570, P. B. Marg, Behind Mahindra Tower,
    Worli, Mumbai - 400 018, India

    View on Google Maps

  • Tel. : 02266322222

    Call us

Prabhudas Lilladher Private Limited | CIN: U67190MH1983PTC029670 | Registered Office Address: 3rd Floor, Sadhana House, 570, P.B. Marg, Worli, Mumbai – 400018, Maharashtra, India | SEBI Registration Details: Stock Broking: INZ000196637 [Membership Codes: NSE – 05977; BSE – 564; MCX – 40690] | Depository Participant: IN-DP-439-2019 [DP Codes: CDSL – 12011300; NSDL – IN303868 | Portfolio Management: INP000009001| Research Analyst: INZ000000271 | Investment Advisors: INA000018267 [BSEASL Membership Code: BASL2042] | AMFI ARN: 3276 | Compliance Officer: Mrs. Snehal Kathrani; Tel: 02266322420; email: co@plindia.com | For any Grievance/ Dispute: Stock Broking; email: grievance-br@plindia.com; Tel: 02266322366; Depository Participant; email: grievance-dp@plindia.com; Tel: 02266322452; Portfolio Management; email: grievance-pms@plindia.com; Tel: 02266322350.

To register your grievance on SCORES log onto: https://scores.gov.in/scores/Welcome.html. Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID

To register your grievance on Smart ODR Portal log onto: Online Dispute Resolution Portal (ODR Portal).

Standard Disclaimers: (a) Investment in securities market are subject to market risks, read all the related documents carefully before investing. (b) Brokerage will not exceed the SEBI prescribed limits. (c) Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The brand name and Logo ‘PL Capital’ are the registered trademarks of Prabhudas Lilladher Advisory Services Private Limited which is the holding company of Prabhudas Lilladher Group of Companies .

Prabhudas Lilladher Private Limited is not associated with any unregulated platform which claims performance/return for algorithmic strategy for trading. Trading with unregulated platforms for algorithmic strategy shall be at your own risk and Prabhudas Lilladher Private Limited or its affiliates shall not be liable for the same.

Risk Disclosure on Derivatives: (a) 9 out of 10 individual traders in equity futures and options segment, incurred net losses. (b) On an average, loss makers registered net trading loss close to ₹ 50,000 (c) Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs. (d) Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source